The pound rose to USD1.3450 late on Friday afternoon in London, compared to USD1.3412 at the equities close on Thursday. The euro traded at USD1.1666, higher against USD1.1631. Against the yen, the ...

Pfizer Inc. grapples with downgraded Q3 earnings forecasts. Leerink Partners slashed their earnings prediction to $0.80 per ...

Goldman Sachs analyst Asad Haider maintained a Hold rating on Pfizer yesterday and set a price target of $27.00. The company’s shares closed yesterday at $23.93. Take advantage of TipRanks Premium at ...

The FTSE 100 edged down on Friday on a mixed day for European equities despite new optimism about an end to the war between ...

Abbott Laboratories’ ABT Established Pharmaceuticals Division (“EPD”) operates solely in emerging geographies, with leading positions in many of the largest and fastest-growing pharmaceutical markets ...

Volatility: Blue chip stocks are usually less volatile than other stocks.

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

UK pharma major GSK (LSE: GSK) today announced that, in connection with the mRNA patent settlement reached between CureVac ...

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more ...

Tokyo, Japan and Cambridge, UK, 8 August 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the second ...

Recent health news highlights include Kenvue cutting its sales forecast amid strategic changes, Eli Lilly raising its profit ...

Tan’s venture capital firm, based in San Francisco, has made significant investments in Chinese tech companies, including Semiconductor Manufacturing International Corp (SMIC), China's largest chip ...